Church health workers aim to slash colorectal cancer risk with screening and lifestyle coaching
NCT ID NCT05174286
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tests whether community health workers can help people at higher risk for colorectal cancer get screened and adopt healthier habits. About 880 adults aged 45 and older who are not up-to-date with screening will be assigned to either a health worker-led program or usual care. The program includes screening advice and a web-based lifestyle program to reduce cancer and heart disease risk.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Community health worker-led screening and lifestyle program (SBIRT and Culturally-adapted ALIVE! program)
- What this could lead to
- If successful, this could show that church-based health worker programs effectively increase colorectal cancer screening and reduce related heart disease risk in high-risk communities.
- What could go wrong
- This is a behavioral study, not a drug trial, so results depend on participant engagement. It may not work in other settings or populations, and screening uptake may not lead to reduced cancer rates.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 880 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Mar 2023
- Expected to finish
-
Aug 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
45 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. English-speaking 2. Aged 45 years and older 3. Not up-to-date with CRC 4. Working telephone 5. Can provide informed consent Exclusion Criteria: 1. Non-English speaking 2. \<45 years old
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Colorectal cancer are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Columbia University Irving Medical Center
RECRUITINGNew York, New York, 10032, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Gut bacteria may hold clues to why some cancer treatments work better
- Burning the edges: a new way to stop colon polyps from coming back
- Missed Follow-Up colonoscopies: do they raise the risk of advanced growths?
- A 2.2 mm scope could spot cancerous tissue in minutes, not days
- The gatekeepers of tumors: scientists probe how blood vessels let immune cells in
- New Antibody-Drug conjugate put to the test against Hard-to-Treat cancers